JP2024537279A - 合成ゲノム編集システム - Google Patents

合成ゲノム編集システム Download PDF

Info

Publication number
JP2024537279A
JP2024537279A JP2024521748A JP2024521748A JP2024537279A JP 2024537279 A JP2024537279 A JP 2024537279A JP 2024521748 A JP2024521748 A JP 2024521748A JP 2024521748 A JP2024521748 A JP 2024521748A JP 2024537279 A JP2024537279 A JP 2024537279A
Authority
JP
Japan
Prior art keywords
sequence
nucleic acid
target
dbd
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024521748A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024537279A5 (https=
JPWO2023057777A5 (https=
Inventor
ラジック モハメド イブラヒム,モハメド
カンワル,ニシャ
ライトスキン,オレーグ
Original Assignee
ペンシル バイオサイエンシズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2114453.0A external-priority patent/GB202114453D0/en
Priority claimed from GBGB2209735.6A external-priority patent/GB202209735D0/en
Application filed by ペンシル バイオサイエンシズ リミテッド filed Critical ペンシル バイオサイエンシズ リミテッド
Publication of JP2024537279A publication Critical patent/JP2024537279A/ja
Publication of JP2024537279A5 publication Critical patent/JP2024537279A5/ja
Publication of JPWO2023057777A5 publication Critical patent/JPWO2023057777A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/80Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/85Fusion polypeptide containing an RNA binding domain
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2024521748A 2021-10-08 2022-10-07 合成ゲノム編集システム Pending JP2024537279A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB2114453.0 2021-10-08
GBGB2114453.0A GB202114453D0 (en) 2021-10-08 2021-10-08 Synthetic genome editing system
GBGB2209735.6A GB202209735D0 (en) 2022-07-01 2022-07-01 Synthetic genome editing system
GB2209735.6 2022-07-01
PCT/GB2022/052555 WO2023057777A1 (en) 2021-10-08 2022-10-07 Synthetic genome editing system

Publications (3)

Publication Number Publication Date
JP2024537279A true JP2024537279A (ja) 2024-10-10
JP2024537279A5 JP2024537279A5 (https=) 2025-10-15
JPWO2023057777A5 JPWO2023057777A5 (https=) 2025-10-15

Family

ID=83902914

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024521748A Pending JP2024537279A (ja) 2021-10-08 2022-10-07 合成ゲノム編集システム

Country Status (9)

Country Link
US (1) US20260009008A1 (https=)
EP (2) EP4636084A3 (https=)
JP (1) JP2024537279A (https=)
KR (1) KR20240082405A (https=)
AU (1) AU2022360286A1 (https=)
CA (1) CA3234338A1 (https=)
ES (1) ES3041112T3 (https=)
IL (1) IL311961A (https=)
WO (1) WO2023057777A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12014501360B1 (en) 2011-12-16 2022-05-20 Targetgene Biotechnologies Ltd Compositions and methods for modifying a predetermined target nucleic acid sequence
WO2020142676A1 (en) * 2019-01-04 2020-07-09 The University Of Chicago Systems and methods for modulating rna
IL292571A (en) * 2019-10-28 2022-06-01 Targetgene Biotechnologies Ltd Pam-reduced and pam-abolished cas derivatives compositions and uses thereof in genetic modulation
GB202010692D0 (en) 2020-07-10 2020-08-26 Horizon Discovery Ltd RNA scaffolds

Also Published As

Publication number Publication date
EP4413140A1 (en) 2024-08-14
EP4413140C0 (en) 2025-08-13
WO2023057777A1 (en) 2023-04-13
CA3234338A1 (en) 2023-04-13
AU2022360286A1 (en) 2024-05-02
EP4636084A3 (en) 2025-12-24
EP4636084A2 (en) 2025-10-22
KR20240082405A (ko) 2024-06-10
IL311961A (en) 2024-06-01
ES3041112T3 (en) 2025-11-07
US20260009008A1 (en) 2026-01-08
EP4413140B1 (en) 2025-08-13

Similar Documents

Publication Publication Date Title
US10633642B2 (en) Engineered CRISPR-Cas9 nucleases
US10526591B2 (en) Engineered CRISPR-Cas9 nucleases
EP4025691B1 (en) Novel, non-naturally occurring crispr-cas nucleases for genome editing
AU2016304795B2 (en) Engineered CRISPR-Cas9 compositions and methods of use
JP2022122910A (ja) 真核ゲノム修飾のための操作されたCas9システム
CN110402287A (zh) CRISPR/Cpf1系统和方法
US20190390229A1 (en) Gene editing reagents with reduced toxicity
WO2017107898A2 (en) Compositions and methods for gene editing
JP2024537279A (ja) 合成ゲノム編集システム
JP2025510007A (ja) カーゴヌクレオチド配列を転位するための系及び方法
CN118318044A (zh) 合成的基因组编辑系统
JP2025508794A (ja) 融合タンパク質
JP2025507642A (ja) 融合タンパク質
HK40078419A (en) Novel, non-naturally occurring crispr-cas nucleases for genome editing
HK40078419B (en) Novel, non-naturally occurring crispr-cas nucleases for genome editing
BR122025004697B1 (pt) Sistemas para modificar um genoma eucariótico, pluralidade de ácidos nucleicos, vetor, e proteína de fusão
BR122025004697A2 (pt) Sistema para modificar uma sequência cromossômica em uma célula eucariótica, pluralidade de ácidos nucleicos, vetor, célula eucariótica, proteína de fusão, composição e usos
HK40040051B (zh) 用於真核基因组修饰的改造的cas9系统

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251006

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251006